Mangoceuticals Inc. logo

MGRX

Mangoceuticals Inc. · NASDAQ

Market cap
$3.6M

Mangoceuticals Inc. (MGRX) is a Misc Health and Biotechnology Services company listed on NASDAQ. In the last 30 days Quantisnow tracked 6 wire items for MGRX, including 4 SEC filings, 1 dividend update and 1 press release or news item. The most recent was published Nov 17, 2026.

Financial highlights

Full financials
Revenue, TTM
$300.5K
Revenue growth
-35.6%
Net income, TTM
-$11.04M
Net margin
-3673.8%
Cash
$659.3K

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

News · 26 weeks33-25%
2026-05-24: 02026-05-31: 02026-06-07: 02026-06-14: 02026-06-21: 02026-06-28: 12026-07-05: 12026-07-12: 02026-07-19: 02026-07-26: 52026-08-02: 72026-08-09: 42026-08-16: 12026-08-23: 02026-08-30: 02026-09-06: 02026-09-13: 02026-09-20: 02026-09-27: 12026-10-04: 72026-10-11: 02026-10-18: 02026-10-25: 02026-11-01: 22026-11-08: 32026-11-15: 1
2026-05-242026-11-15
Mix1590d
  • SEC Filings8(53%)
  • Insider3(20%)
  • Other2(13%)
  • Offering1(7%)
  • Dividends1(7%)
Activity · 52 weeks6236 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

MGRX FAQ

9 questions
  • What is the latest news on MGRX?
    In the last 30 days Quantisnow tracked 6 wire items for MGRX: 4 SEC filings, 1 dividend update and 1 press release or news item. The most recent was published on November 17, 2026.
  • What is MGRX revenue?
    Mangoceuticals Inc. (MGRX) reported $300.5K of revenue for the twelve months ended Sep 30, 2026. That is down 35.6% from the year before. Revenue for fiscal 2025 was $456.0K.
  • Is MGRX profitable?
    No. Mangoceuticals Inc. reported a net loss of $11.04M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does MGRX have?
    Mangoceuticals Inc. reported $659.3K in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does MGRX stock trade?
    Mangoceuticals Inc. (MGRX) is listed on NASDAQ.
  • What sector and industry is MGRX in?
    Mangoceuticals Inc. operates in the Health Care sector, Misc Health and Biotechnology Services industry.
  • When did Mangoceuticals Inc. go public?
    Mangoceuticals Inc. (MGRX) completed its IPO in 2023.
  • What companies are similar to MGRX?
    Notable peers in the same industry include DVA (DaVita Inc.), AGL (agilon health inc.), FMS (Fresenius Medical Care AG), PARK (Park Dental Partners Inc.), PGNY (Progyny Inc.). Compare MGRX side-by-side with any of them on Quantisnow.
  • How can I track MGRX on Quantisnow?
    Quantisnow aggregates Mangoceuticals Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MGRX to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change